What's next for Giannis and the Bucks? Is this LeBron James' last year with the Lakers? These questions will define the ...

With healthcare at a key crossroads of policy, technology, and science, Sanofi CEO Paul Hudson shares the Big Pharma’s ...

Global Value Investment Corporation (GVIC) announced today it has been named to the celebrated PSN Top Guns List of best performing separate accounts, managed accounts, and managed ETF strategies for ...

Increasing insurance costs are forcing some homeowners to strategize for a future in which they perhaps try to forego ...

Not all 0-2s come from the same gene pool ... the problem in Miami is how the Dolphins have looked in losses to the Colts and ...

While the FOMC decision and commentary helped boost crypto miner CleanSpark, a possible short squeeze could be the driver for ...

The average retirement plan participants between the ages of 45 and 54 had an average balance of $168,646 in 2023, according ...

Chobani customers are calling for a boycott of the popular yogurt brand after it announced a new partnership with a company cofounded by Ivanka Trump ...

Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant. Additional cost optimization measures expected to realize total ...

The report highlights expanded disclosures and formal alignment with the Sustainability Accounting Standards Board (SASB) and Task Force on Climate-Related Financial Disclosures (TCFD) recommendations ...

The U.S. Food and Drug Administration (FDA) approved ZURZUVAE in August 2023 and the Drug Enforcement Agency (DEA) scheduled it as a Class IV controlled substance in October 2023. In August 2025, ...

Fidelity Minerals Corp. is pleased to announce that it has arranged a non-brokered private placement financing of up to 12,500,000 units at a price of C$0.10 per unit for total gross proceeds of up to ...